Torigen Pharmaceuticals Secures $3.1 Million in Series A Financing

Financial Content – Torigen Pharmaceuticals, a company developing personalized cancer immunotherapies for the veterinary market, announced today the completion of a $3.1 million Series A financing round led by Connecticut Innovations, which included the conversion of outstanding convertible debt and interest.



Celebrating UConn Inventors

UConn Today – “I have not failed. I’ve just found 10,000 ways that won’t work.” “Our greatest weakness lies in giving up. The most certain way to succeed is always to try just one more time.” “Many of life’s failures are people who did not realize how close they were to success when they gave up.”


EBV Alum: ‘To Do What You Love is Priceless’

EBV alumnus Jason Otrin (Nathan Oldham/UConn School of Business)
EBV alumnus Jason Otrin (Nathan Oldham/UConn School of Business)

Imagine a young child wandering alone in the woods on a frigid afternoon, with each passing minute decreasing the likelihood of a successful rescue.

UConn alumnus Jason Otrin would like to encourage emergency responders in Connecticut, and across the nation, to adopt the use of drones for such public-safety emergencies. Continue Reading